These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20431846)

  • 1. Anticoagulant therapy in critical organ ischaemia/reperfusion injury.
    Loubele ST; ten Cate H; Spronk HM
    Thromb Haemost; 2010 Jul; 104(1):136-42. PubMed ID: 20431846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of coagulation inhibitors in inflammation.
    Esmon CT
    Thromb Haemost; 2001 Jul; 86(1):51-6. PubMed ID: 11487041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a semi-synthetic N-,O-sulfated glycosaminoglycan K5 polysaccharide derivative in a rat model of cerebral ischaemia/reperfusion injury.
    Collino M; Castiglia S; Manoni M; Salsini L; Chini J; Masini E; Fantozzi R
    Thromb Haemost; 2009 Nov; 102(5):837-45. PubMed ID: 19888517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anticoagulant treatment on intestinal ischaemia and reperfusion injury in rats.
    Olanders K; Börjesson A; Zhao X; Andersson R
    Acta Anaesthesiol Scand; 2005 Apr; 49(4):517-24. PubMed ID: 15777300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C reduces endotoxin-induced white matter injury in the developing rat brain.
    Yesilirmak DC; Kumral A; Baskin H; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Brain Res; 2007 Aug; 1164():14-23. PubMed ID: 17644074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammation.
    Loubele ST; Spek CA; Leenders P; van Oerle R; Aberson HL; Hamulyák K; Ferrell G; Esmon CT; Spronk HM; ten Cate H
    Arterioscler Thromb Vasc Biol; 2009 Jul; 29(7):1087-92. PubMed ID: 19372456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C protects against renal ischaemia/reperfusion injury, independent of its anticoagulant properties.
    Lattenist L; Jansen MP; Teske G; Claessen N; Meijers JC; Rezaie AR; Esmon CT; Florquin S; Roelofs JJ
    Thromb Haemost; 2016 Jul; 116(1):124-33. PubMed ID: 27052416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C attenuates intestinal mucosal injury after mesenteric ischemia/reperfusion.
    Teke Z; Sacar M; Yenisey C; Atalay AO; Kavak T; Erdem E
    J Surg Res; 2008 Oct; 149(2):219-30. PubMed ID: 18533185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C--an anticoagulant that does more than stop clots.
    Jackson CJ; Xue M
    Int J Biochem Cell Biol; 2008; 40(12):2692-7. PubMed ID: 18249579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective.
    Cheng T; Liu D; Griffin JH; Fernández JA; Castellino F; Rosen ED; Fukudome K; Zlokovic BV
    Nat Med; 2003 Mar; 9(3):338-42. PubMed ID: 12563316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action.
    Chen B; Liao WQ; Xu N; Xu H; Wen JY; Yu CA; Liu XY; Li CL; Zhao SM; Campbell W
    Brain Res; 2009 Jun; 1273():129-37. PubMed ID: 19362080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C prevents hepatic ischaemia-reperfusion injury in rats.
    Kuriyama N; Isaji S; Hamada T; Kishiwada M; Ohsawa I; Usui M; Sakurai H; Tabata M; Suzuki K; Uemoto S
    Liver Int; 2009 Feb; 29(2):299-307. PubMed ID: 18507760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcirculatory disorders in sepsis and transplantation: therapy with natural coagulatory inhibitors antithrombin and activated protein C.
    Hoffmann JN; Fertmann JM; Jauch KW
    Curr Opin Crit Care; 2006 Oct; 12(5):426-30. PubMed ID: 16943720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of activated protein C on neonatal hypoxic ischemic brain injury.
    Yesilirmak DC; Kumral A; Tugyan K; Cilaker S; Baskin H; Yilmaz O; Duman N; Ozkan H
    Brain Res; 2008 May; 1210():56-62. PubMed ID: 18420181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury.
    Frank RD; Holscher T; Schabbauer G; Tencati M; Pawlinski R; Weitz JI; Mackman N
    Thromb Haemost; 2006 Dec; 96(6):802-6. PubMed ID: 17139376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anticoagulant strategies on activation of inflammation and coagulation.
    Feistritzer C; Wiedermann CJ
    Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
    Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
    Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.